All Industries

Top Life Sciences Companies

1,069 Life Sciences companies, sorted by total funding raised.

Agios PharmaceuticalsIPO

Agios develops medicines for rare diseases by applying cellular-metabolism science, with programs...

Cambridge, United States501–1000Biotech, Drug Discovery
Series CTotal funding$241.0MNov 2011
Elligo Health Research

Elligo Health Research accelerates clinical trials through EHR data, proprietary technology, and ...

Austin, United States201–500Biotech, Healthcare
Series ETotal funding$236.0MSep 2021
Actis Asia Real Estate 2 RX Co-Investment

Rx is a real estate platform sponsored by Actis which will develop, acquire and manage a portfoli...

Hyderabad, IndiaInfrastructure, Life Sciences
Private EquityTotal funding$231.5MMay 2022
Truvian

Develops an automated benchtop blood-testing analyzer that delivers lab-accurate routine blood te...

San Diego, United States51–200Life Sciences, Diagnostics
Growth EquityTotal funding$225.3MJul 2024
Basecamp Research

Builds evolutionary biological datasets and foundation AI models to design proteins and therapeut...

London, United Kingdom11–50Artificial Intelligence, Biotech
Series CTotal funding$220.0MSep 2026
PB Health

PB Health is a comprehensive healthcare delivery platform comprising network of hospitals, preven...

Gurugram, India51–200Life Sciences, Healthcare
SeedTotal funding$218.0MMay 2025
PharvarisIPO

Pharvaris is a clinical-stage company focused on the discovery and development of treatments for ...

Zug, Switzerland51–200Biotech, Healthcare
Private EquityTotal funding$216.0MJun 2023
Satellite Bio

Develops off-the-shelf liver cell therapies that deliver functional hepatocytes to restore liver ...

Cambridge, United States11–50Biotech, Life Sciences
Series BTotal funding$215.5MJan 2024
DP Technology

DP Technology creates AI scientists, intelligent systems, and scientific tools spanning modern re...

Beijing, China201–500Artificial Intelligence, Drug Discovery
Series CTotal funding$213.7MDec 2025
CANbridgeIPO

CANbridge is a biotechnology company focused on developing and commercializing rare disease thera...

Burlington, China201–500Biotech, Healthcare
Series ETotal funding$211.0MDec 2020
Autobahn Therapeutics

Autobahn Therapeutics is a clinical-stage biotech developing brain-targeting small-molecule thera...

San Diego, United States11–50Life Sciences
Series CTotal funding$208.7MJul 2024
ImmunocoreIPO

Immunocore is a biotechnology company focused on therapies for oncology, viral diseases, and auto...

Abingdon, Oxon, United KingdomHealthcare, Life Sciences
Series CTotal funding$205.0MJan 2021
SchrödingerIPO

Physics-based computational platform for molecular design that helps pharmaceutical, biotechnolog...

New York, United States501–1000Artificial Intelligence, Biotech
GrantTotal funding$205.0MJul 2024
HarmonyCares

Provides physician-led, value-based in-home primary care and ancillary services for medically com...

Troy, United States1001–5000Healthcare, Life Sciences
Growth EquityTotal funding$200.0MJul 2024
SeerIPO

Seer develops the Proteograph platform enabling deep, unbiased proteomics discovery at scale for ...

Redwood City, United States51–200Biotech, Life Sciences
Series DTotal funding$197.5MJul 2020
CinCor PharmaAcquired

CinCor Pharma is a clinical-stage biopharmaceutical company with a mission to bring innovation to...

United States1–10Life Sciences
Series BTotal funding$193.0MOct 2021
Cellanome

Biotechnology company developing an automated platform for multimodal single-cell analysis, enabl...

Foster City, United States51–200Biotech, Life Sciences
Series BTotal funding$192.8MJan 2024
Fabric

Fabric is a healthcare technology company offering an AI-powered care enablement platform that un...

New York, United States201–500Artificial Intelligence, E-Commerce
Series ATotal funding$190.0MFeb 2024
TScan TherapeuticsIPO

Clinical-stage biotechnology company developing T cell receptor (TCR)-engineered T cell therapies...

Waltham, United States51–200Biotech, Healthcare
Corporate RoundTotal funding$190.0MDec 2024
10x GenomicsIPO

10x Genomics develops single-cell, spatial, and in situ genomic analysis instruments, reagents, a...

Pleasanton, United States1001–5000Biotech, Life Sciences
Series DTotal funding$187.6MApr 2018
Watershed Informatics

Cloud platform for omics data analysis and collaboration, serving biopharma and research teams to...

Cambridge, United States11–50Data & Analytics, Healthcare
Series CTotal funding$184.5MFeb 2024
Genome Medical

Telehealth genetic counseling and test-support for patients, providers, and life-sciences partner...

South San Francisco, United States51–200Digital Health, Genomics
Series DTotal funding$183.3MOct 2024
Caribou BiosciencesIPO

Clinical-stage biopharmaceutical company developing genome-edited allogeneic CAR-T cell therapies...

Berkeley, United States51–200Biotech, Healthcare
Corporate RoundTotal funding$181.0MJul 2023
AdageneIPO

Adagene is a clinical-stage biotechnology company focused on developing innovative antibodies wit...

Suzhou, China51–200Artificial Intelligence, Biotech
Corporate RoundTotal funding$180.0MJul 2025
VectorY

VectorY develops one-time precision treatments for neurodegenerative diseases by delivering thera...

Amsterdam, Netherlands51–200Life Sciences
Series ATotal funding$175.6MNov 2023